Use of in vitro human skin membranes to model and predict the effect of changing blood flow on the flux and retention of topically applied solutes

Journal of Pharmaceutical Sciences

Volumn 97, Issue 8, 2008, Pages 3442-3450

  Cross, Sheree E ^a   Roberts, Michael S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Epithelial delivery permeability; Skin; Structure transport relationship; Targeted drug delivery; Transdermal drug delivery

Indexed keywords

ALCOHOL; BUTANOL; DECANOL; HEXANOL; OCTANOL; STEROID;

ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DIFFUSION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STRUCTURE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIPOPHILICITY; MOLECULAR SIZE; MOLECULAR WEIGHT; PHYSICAL CHEMISTRY; SKINFOLD THICKNESS; STRATUM CORNEUM; TISSUE LEVEL;

EID: 52449091772     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21253     Document Type: Article

References (18)

1. Hawkins GS, Reifenrath WG. 1986. Influence of skin source, penetration cell fluid and partition coefficient on in vitro skin penetration. J Pharm Sci 75:378-381.
2. Wilkinson SC, Maas WJM, Nielsen JB, Greaves LC, van de Sandt JJM, Williams FM. 2006. Interactions of skin thickness and physicochemical properties of test compounds in percutaneous penetration studies. Int Arch Occup Environ Health 79:405-413.
3. Reifenrath WG, Hawkins GS, Kurtz MS. 1991. Percutaneous penetration and skin retention of topically applied compounds. J Pharm Sci 80:526-532.
4. Roberts MS. 1991. Structure-permeability considerations in percutaneous absorption. In: Scott RC, Guy RH, Hadgraft H, Bodde HE, editors. Predictions of percutaneous penetration: Methods, measurements, modelling. Vol. 2. Oxford: Information Press Ltd. pp. 210-228.
5. Siddiqui O, Roberts MS, Polack AE. 1989. Percutaneous absorption of steroids: Relative contributions of epidermal penetration and dermal clearance. J Pharmacokin Biopharm 17:405-424.
6. Tsai JC, Weiner N, Flynn GL, Ferry JJ. 1994. Drug and vehicle deposition from topical applications: Localization of minoxidil within the skin strata of the hairless mouse. Skin Pharmacol 7:262-269.
7. Cross SE, Magnusson BM, Anissimov YG, Winckle G, Roberts MS. 2003. Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers. J Invest Dermatol 120:759-764.
8. Magnusson BM, Cross SE, Winckle G, Roberts MS. 2006. Percutaneous absorption of steroids: Determination of permeability and tissue reservoir characteristics in human skin layers. Skin Pharmacol Physiol 19:336-342.
9. Chilcott RP, Jenner J, Carrick SA, Hotchkiss SAM, Rice P. 2000. Human skin absorption of bis-2(chlor-oethyl)sulphide (sulphur mustard) in vitro. J Appl Toxicol 20:349-355.
10. Van de Sandt JJM, Meuling WJA, Elliott GR, Cnubben NHP, Hakkert B. 2000. Comparative in vitro-in vivo percutaneous absorption of the pesticide propoxur. Toxicol Sci 58:15-22.
11. Perkins NC, Heard CM. 1999. In vitro dermal and transdermal delivery of doxycycline from ethanol/ migliol 840 vehicles. Int J Pharm 190:155-164.
12. Baker EJ, Hadgraft J. 1995. In vitro percutaneous absorption of arildone, a highly lipophilic drug, and the apparent no-effect of the penetration enhancer azone in excised human skin. Pharm Res 12:993-997.
13. Cnubben NHP, Elliott GR, Hakkert BC, Meuling WJA, van de Sandt JJM. 2002. Comparative in vitro - in vivo percutaneous penetration of the fungicide ortho-phenylphenol. Reg Toxicol Pharmacol 35:198-208.
14. Anderson BD, Higuchi WI, Raykar PV. 1988. Heterogeneity effects on permeability-partition coefficient relationships in human stratum corneum. Pharm Res 5:566-573.
15. Wilkinson SC, Williams FM. 2002. Effects of experimental conditions on absorption of glycol ethers through human skin in vitro. Int Arch Occup Environ Health 75:519-527.
16. Kempainnen BW, Reifenrath WG, Stafford RG, Metha M. 1991. Methods for in vitro skin absorption studies of a lipophilic toxin produced by red tide. Toxicology 66:1-17.
17. Supersaxo A, Hein WR, Steffen H. 1990. Recombi-nant interferon alpha 2a: Delivery to lymphoid tissue by selected modes of application. Pharm Res 7:167-169.
18. Cross SE, Wu ZY, Roberts MS. 1993. Subcutaneous absorption kinetics of interferon and other solutes. J Pharm Pharmacol 45:606-609.